Enzymes Sustainable Alternatives with Remarkable Scope

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • Dec 2014
  • 172 pages

REPORT HIGHLIGHTS The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of 2019 at compound annual growth rate (CAGR) of 10.6%. This report provides: An overview of the global ...

Industries: Biopharmaceutical | Countries: World

Antibody Drugs: Technologies and Global Markets

Antibody Drugs: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • by BCC Research
  • Dec 2014
  • 141 pages

REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019. This report provides: ...

Industries: Biopharmaceutical | Countries: World

Biosimilars Business Review Q4 2014

Biosimilars Business Review Q4 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 16 pages

Industry Trend Analysis - US Biosimilar Market Edged Closer In 2014, Intensifying Key Debates Industry Brief - Epirus Enters China Collaboration With Livzon Industry Trend Analysis - Amgen's Biosimilar Programme Progresses Industry Brief - STADA In-Licenses Biosimilar Teriparatide Industry Brief - Baxte ...

Industries: Biopharmaceutical | Countries: India, China, United States, World

Quantrx Biomedical Corporation

Quantrx Biomedical Corporation

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for Quantrx Biomedical Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

Zhenxing Biopharmaceutical & Chemical Inc

Zhenxing Biopharmaceutical & Chemical Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for Zhenxing Biopharmaceutical & Chemical Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Biopharmaceutical

The Russian Biopharmaceuticals and Biomedicine Market : From Import Substitution to Innovation

The Russian Biopharmaceuticals and Biomedicine Market : From Import Substitution to Innovation

  • $ 1 500
  • Industry report
  • by Frost & Sullivan
  • December 2014
  • 89 pages

Executive Summary •The Russian biopharmaceuticals market was valued at $ x billion in 2013 and is projected to grow at a CAGR of x % till 2018. •The ageing population and increasing disease burden are key long-term growth factors for the biotech industry. By 2025, almost a quarter of the Russian ...

Industries: Biopharmaceutical | Countries: Russian Federation

RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for RegeneRx Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Biopharmaceutical

Accentia Biopharmaceuticals, Inc.

Accentia Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for Accentia Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Biopharmaceutical

XTL BIopharmaceuticals Limited

XTL BIopharmaceuticals Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 56 pages

A textual analysis of the financial results for XTL BIopharmaceuticals Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical | Countries: Israel

Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • December 2014
  • 55 pages

A textual analysis of the financial results for Keryx Biopharmaceuticals, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Biopharmaceutical

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.